Veteran San Francisco Bay Area metallers SKINLAB will release their new album, "Venomous", on October 25 via Art Is War Records, The disc was engineered, produced and mixed by Ulrich Wild, who stated about the effort: "I love working with SKINLAB. This album is heavy and intense. As brutal as it is, it gets very melodic at times, and Steev's [Esquivel, bass/vocals] iconic voice is tying it all together." Esquivel said: "'Venomous' is the album that best represents SKINLAB in 2019 — heavy, brutal and honest. We feel that we've stood the test of time without losing integrity and chasing trends. We're back stronger than ever." "Venomous" features 10 tracks recorded over the duration of 2019: 01. The Fury Within The Fire 02. Amerikill 03. Venomous 04. Overcoming 05. Demons 06. For The Fallen 07. Far From Grace 08. Eyes Of Your Enemy 09. End Of Silence 10. The Family Pre orders and bundles are available at this location. Join SKINLAB on November 2 for the "Venomous" record-release party at The Metro in Oakland, California. The official visualizer for the album's first single, "Overcoming", can be seen below. "Venomous" marks SKINLAB's recording debut with new drummer Fabian Vestod, who joined the band last year following the exit of the longtime drummer Paul Hopkins. Esquivel said: "Fabian, who is no stranger to SKINLAB, has been friends with the band for many years. Fabian came in strong and started recording demos and immediately became the obvious choice that he was our guy." Last year, SKINLAB announced the return of guitarist Steve Green, best known to fans as Snake. Snake remains a member of THE DEVIL IN CALIFORNIA, with whom he's been performing since 2015. Formed in 1994, SKINLAB has released four studio albums: 1997's "Bound, Gagged And Blindfolded", 1999's "Disembody: The New Flesh", 2002's "ReVolting Room" and 2009's "The Scars Between Us". SKINLAB has had different lineups throughout its history, with Esquivel as the only mainstay. The band's current lineup is completed by lead guitarist Marcos Medina Rivera.
Continue reading...
Continue reading...
